Previous clinical studies have shown that low serum adropin levels were associated with severity of coronary atherosclerosis, as reflected by higher SYNTAX score and Gensini score, either in patients undergoing percutaneous coronary intervention or in individuals without CKD [22,23,24]. The gene discussed is ENHO; the disease is chronic kidney disease.